SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

Financials Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

002603

CNE1000015S0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
18.83 ^CNY	-1.15%		-3.19%	-18.38%

26/04	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/04	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	14,801	30,365	32,746	50,054	38,543	31,459	-	-
Enterprise Value (EV) ¹	14,801	30,365	32,746	49,007	39,009	30,230	29,337	28,496
P/E ratio	24.9 x	25 x	24.4 x	21.2 x	28.5 x	20.2 x	12.9 x	14.2 x
Yield	1.61%	3.92%	1.53%	1.67%	1.3%	1.9%	2.47%	2.71%
Capitalization / Revenue	2.54 x	3.46 x	3.24 x	3.99 x	3.74 x	2.77 x	2.22 x	2.15 x
EV / Revenue	2.54 x	3.46 x	3.24 x	3.91 x	3.78 x	2.66 x	2.07 x	1.94 x
EV / EBITDA	15.2 x	17.7 x	16.9 x	15 x	16.8 x	12 x	6.36 x	9.34 x
EV / FCF	-	6,87,45,950 x	-	-	-	-	-	-
FCF Yield	-	0%	-	-	-	-	-	-
Price to Book	1.88 x	3.44 x	3.61 x	4.58 x	3.37 x	2.45 x	2.05 x	1.96 x
Nbr of stocks (in thousands)	16,67,081	16,67,081	16,70,705	16,70,705	16,70,705	16,70,705	-	-
Reference price ²	8.879	18.21	19.60	29.96	23.07	18.83	18.83	18.83
Announcement Date	27/02/20	25/02/21	28/04/22	25/04/23	26/04/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	5,825	8,782	10,117	12,533	10,318	11,358	14,170	14,653
EBITDA ¹	973.9	1,713	1,939	3,271	2,321	2,518	4,613	3,052
EBIT ¹	710.2	1,438	1,569	2,830	1,780	1,963	2,917	2,769
Operating Margin	12.19%	16.37%	15.51%	22.58%	17.25%	17.28%	20.58%	18.9%
Earnings before Tax (EBT) ¹	707.9	1,422	1,554	2,781	1,684	1,903	2,881	2,714
Net income ¹	606.5	1,219	1,344	2,362	1,352	1,557	2,432	2,216
Net margin	10.41%	13.88%	13.28%	18.84%	13.11%	13.71%	17.16%	15.12%
EPS ²	0.3571	0.7286	0.8044	1.414	0.8095	0.9339	1.456	1.324
Free Cash Flow	-	441.7	-	-	-	-	-	-
FCF margin	-	5.03%	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	25.79%	-	-	-	-	-	-
FCF Conversion (Net income)	-	36.24%	-	-	-	-	-	-
Dividend per Share ²	0.1429	0.7143	0.3000	0.5000	0.3000	0.3571	0.4651	0.5110
Announcement Date	27/02/20	25/02/21	28/04/22	25/04/23	26/04/24	-	-	-

¹CNY in Million²CNY

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	466	-	-	-
Net Cash position ¹	-	-	-	1,048	-	1,230	2,123	2,963
Leverage (Debt/EBITDA)	-	-	-	-	0.2005 x	-	-	-
Free Cash Flow	-	442	-	-	-	-	-	-
ROE (net income / shareholders' equity)	7.83%	14.5%	14.9%	23.6%	12.2%	12.4%	15.8%	14%
ROA (Net income/ Total Assets)	6.88%	11.9%	11%	15.9%	-	9.63%	12.3%	11.5%
Assets ¹	8,813	10,281	12,199	14,864	-	16,179	19,753	19,254
Book Value Per Share ²	4.710	5.290	5.430	6.540	6.850	7.690	9.190	9.610
Cash Flow per Share ²	0.0400	0.9400	0.3200	2.090	0.0900	1.050	1.910	1.560
Capex ¹	454	1,144	672	214	310	429	990	470
Capex / Sales	7.8%	13.03%	6.65%	1.7%	3%	3.78%	6.99%	3.21%
Announcement Date	27/02/20	25/02/21	28/04/22	25/04/23	26/04/24	-	-	-

¹CNY in Million²CNY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.83 CNY

Average target price

20.09 CNY

Spread / Average Target

+6.69%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.38%	4.35B
DONG-E-E-JIAO CO.,LTD.	+39.33%	6.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.17%	3.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.98%	3.15B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.41%	2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+48.74%	1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-4.82%	1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-1.24%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.96%	1.6B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+39.87%	1.44B

Alternative Medicine